 Home > Medical News > Latest Medical News > Subcutaneous injection of PD-L1 antibody envolimab was again approved as an orphan drug by the U.S. FDA

Subcutaneous injection of PD-L1 antibody envolimab was again approved as an orphan drug by the U.S. FDA

 Last Update: 2021-08-16
 Source: Internet
 Author: User

Tags

jardiance drug class

codeine drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Corning Jereh announced that the company's self-developed recombinant humanized PD-L1 single domain antibody envolimab injection has been granted orphan drug designation by the US Food and Drug Administration for the treatment of soft tissue sarcoma

At present, the registration clinical trial of envolimab injection for the treatment of patients with pleomorphic sarcoma (UPS)/fibrous histiocytosarcoma (MFS) who have failed the previous treatment with non-immune checkpoint inhibitors is in progress, and the clinical trial design has been changed The US partner TRACON Pharmaceuticals (hereinafter referred to as "TRACON", NASDAQ: TCON) will be announced in the form of a poster at the ASCO 2021 annual meeting

Note: The original text has been deleted

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.